NEW YORK, Aug. 13, 2025 /PRNewswire/ — The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2025 Prix Galien USA Award nominees for “Best Digital Health Solution,” “Best Medical Technology,” “Incubators, Accelerators and Equity,” and “Best Startup.” Winners will be announced during the Prix Galien USA Awards Ceremony on October 30, 2025, at the American Museum of Natural History in New York City.
“As Jury Chair, I am honored to recognize these exceptional nominees who exemplify the transformative power of innovation in medical technology, digital health, and entrepreneurship,” said Kenneth C. Frazier, Chair of the Jury, Prix Galien USA Awards Committee. “Their groundbreaking work represents the future of healthcare and our shared commitment to improving lives through scientific excellence.”
The 2025 Prix Galien USA nominees include products from the following categories: “Best Digital Health Solution” – 25 nominees; “Best Medical Technology” – 25 nominees; “Best Incubators, Accelerators and Equity” – 12 nominees, and “Best Startup” – 53 nominees.
To qualify, each candidate must be U.S. Food and Drug Administration (FDA) approved for marketing within the last five years and demonstrate tremendous potential to improve human health. Sales data are not considered by the nominating committee in their award nominee selection, only science and health impact.
Best Digital Health Solution (Nominees)
| Abbott | NeuroSphere™ Virtual Clinic |
| AdhereTech | Aidia System |
| All4Cure, Inc. | All4Cure Platform, MyelomaMap (TM), TrialMatchMM |
| Aptar Digital Health | Migraine Buddy’s Weather and Trigger Advanced Reports |
| Beaconcure | Verify |
| Cleerly | Cleerly LABS Plaque Analysis |
| Clinical ink | GlucoseReady (TM) |
| DNAnexus + BoehringerIngelheim JointSubmission | Project PRISM/Project CRYPTx |
| Empatica | Empatica Health Monitoring Platform |
| Evinova | Unified Trial Solution |
| First Ascent Biomedical Inc | xDRIVE/DxPP – Ex Vivo Drug Response Identification & Validation Engine / Drug Prediction Platform |
| Future Doctor Inc | MedGPT – AI Digital Twin of Doctors |
| Helfie AI | Helfie AI |
| MPA | MyPsychAdmin – The only AI solution that frees Mental Health Practitioners from computers/admin so they can spend more time with their patients. |
| Mymee | Mymee’s product is a proprietary personalized trial & care platform for rheumatic autoimmune patients who can no longer control disease flares with prescription therapies. |
| NeuraLight | NeuraLight platform |
| Otsuka Precision Health | Rejoyn |
| ŌURA | Oura Ring 4 |
| Patientory, Inc. | Patientory Digital Health Data Wallet |
| RapidAI | Rapid Aneurysm |
| Recursion | Recursion Operating System (OS): end-to-end AI-driven drug discovery and development platform |
| TECHMEDO Inc. | Healthcare Operating System |
| University of Rochester – Wilmot Cancer Institute | University of Rochester – Wilmot Cancer Institute’s Hyperion |
| WARD 24/7 | WARD Clinical Support System (WARD-CSS) |
| Wheel | Wheel Horizon |
Best Medical Technology (Nominees)
| Abbott | Esprit™ BTK Everolimus Eluting Resorbable Scaffold System |
| Abbott | AVEIR™ Dual Chamber (DR) Leadless Pacemaker System |
| Abbott | TriClip™ G4 System |
| Alcon | TOTAL30® Soft Contact Lenses |
| Beyond Air, Inc. | LungFit® PH |
| bioMérieux | BIOFIRE® SPOTFIRE® System and BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel |
| BioProtect | BioProtect Balloon Spacer |
| Body Vision Medical LTD. | LungVision® |
| Boston Scientific | FARAPULSE™ Pulsed Field Ablation System |
| Cresilon | TRAUMAGEL® |
| Edwards Lifesciences | Edwards SAPIEN 3 Ultra RESILIA Transcatheter Aortic Heart Valve |
| Edwards Lifesciences | Edwards EVOQUE Transcatheter Tricuspid Valve Replacement System |
| ENDOLOGIX LLC | DETOUR System |
| Establishment Labs Holdings Inc. | Motiva Flora® SmoothSilk® Tissue Expander |
| Guardant Health | Guardant360® CDx |
| Impulse Dynamics | Optimizer® Smart Mini System |
| Medtronic | MiniMed™ 780G automated insulin delivery system |
| Medtronic | Symplicity Spyral™ Renal Denervation System |
| Medtronic | Inceptiv™ SCS |
| OUR United Corporation | TaiChiPro® |
| Perspectum | CoverScan |
| Polarean | XENOVIEW HPX System |
| RefleXion Medical | RefleXion® X1 with SCINTIX® biology-guided radiotherapy |
| Smith & Nephew, Inc. | CORI Surgical System |
| Terumo Aortic | Thoraflex Hybrid |
Best Incubators, Accelerators and Equity (Nominees)
| AVANT BIO | AVANT BIO Fund II LP |
| Calibr-Skaggs Institute for Innovative Medicines | Calibr-Skaggs Drug Accelerator |
| Cornell University | Center for Life Science Ventures |
| Cross-Border Impact Ventures | Women’s and Children’s Health Technology Fund |
| Cube Labs | Cube Labs |
| EIT Health | EIT Health Accelerator |
| Endless Frontier Labs | Endless Frontier Labs |
| MATTER | SMILE Health |
| Mayo Clinic | Mayo Clinic and Arizona State University Alliance for Health Care Accelerator |
| McGill Dobson Centre for Entrepreneurship | McGill Dobson Centre for Entrepreneurship |
| Nucleate | The Activator |
| OROT – CIUSSS West-Central Montreal | OROT – Connected Health Incubator, CIUSSS West Central (Montréal) |
Best Startup (Nominees)
| Actipulse Neuroscience | Actipulse |
| Adaptilens, Inc. | |
| ADVANCED BIODESIGN | |
| ALGA BIOLOGICS | ALGA BIOLOGICS |
| Ascidian Therapeutics | |
| BigHat Biosciences | Milliner™ |
| Bitterroot Bio | |
| Bloqcube Inc. | |
| Canary Medical | Canary Medical |
| Click Therapeutics | Prescription Digital Therapeutics |
| CUTISS AG | |
| Dren Bio | |
| Duo Oncology | Duo Oncology |
| Esperto Medical, Inc. | |
| Ganymed Robotics | Ganymed Robotics |
| Gatehouse Bio, Inc. | |
| Geneos Therapeutics | GNOS-PV02+INO-9012 followed by intradermal electroporation. Personalized Therapeutic Cancer Vaccine |
| Gleamer | |
| Hope Medicine | |
| Imaginostics, Inc. | |
| Immunis, Inc. | |
| Insilico Medicine | |
| Intrepid Labs | |
| Kapsule | Kapsule Terminal |
| LEAF4Life, Inc. | |
| Libera Bio S.L. | MPN Technology |
| magAssist Co., Ltd. | |
| Mammoth Biosciences | |
| Manus Neurodynamica | NeuroMotor Pen™ |
| MediVIE Tech | |
| Micron Biomedical, Inc. | |
| Navigation Sciences, Inc. | |
| Nona Biosciences | |
| Nospharma | |
| Paradigm Therapeutics | |
| Qubit Pharmaceuticals | Qubit Pharmaceuticals |
| Quercis | |
| REGEnLIFE | |
| Resuscitec GmbH | |
| SEED Therapeutics Inc. | |
| Seismic Therapeutic | |
| SFA Therapeutics, Inc. | |
| Shenzhen ReeToo Biotechnology Co., Ltd. | |
| SIMEDYS | SIMEDYS |
| SmartBiotic | Antimicrobial Management by Smartbiotic |
| Strand Therapeutics | |
| SURGE Therapeutics | |
| TargED Biopharmaceuticals B.V. | |
| Turbine Simulated Cell Technologies Limited | |
| ViCardia Therapeutics, Inc. | |
| Vocxi Health | MyBreathPrint |
| XaTek Inc. | ClotChip |
| Zest Health | Zest Health |
Bruno Cohen, Chairman of The Galien Foundation, commented, “We are honored to recognize this year’s outstanding Prix Galien USA nominees, whose innovation in medical technology, digital health, and entrepreneurship demonstrates the progress that moves healthcare forward. Their achievements reveal the extraordinary potential of science to change lives.”
Prix Galien Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup Committee 2025
Kenneth C. FRAZIER
Committee Chair, Former Chairman & CEO Merck
Roch DOLIVEUX
Honorary CEO, UCB
Dr. Mikael DOLSTEN
Chief Scientific Officer & President, Pfizer Research and Development
Alex GORSKY
Former CEO & Executive Chairman, Johnson & Johnson
Penny HEATON
Global Therapeutic Area Head, Vaccines, Janssen
Sheri McCOY
Board of Directors, AstraZeneca, Former CEO, Avon
Joel S. MARCUS
Executive Chairman & Founder, Alexandria
Elias ZERHOUNI
Former Head of Global R&D, Sanofi
About The Galien FoundationThe Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives. The late Professor Elie Wiesel, 1986 Peace Nobel Laureate, is The Honorary Founding President of The Galien Foundation.
The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries, Africa and an inaugural chapter established in India in 2024. The Prix Galien was created in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
For more information, visit www.galienfoundation.org.
SOURCE The Galien Foundation
0 comments